Table 2.
Associations of HIV status with mpox virus infection, mpox vaccination hesitation, and consultation hesitation for mpox.
| Outcomes | % (n/N) | Model 1 |
Model 2 |
Model 3 |
|||
|---|---|---|---|---|---|---|---|
| OR (95% CI) | P-value | aOR (95% CI) | P-value | aOR (95% CI) | P-value | ||
| Mpox virus infection | |||||||
| Non-HIV | 0.55 (29/5276) | 1 (reference) | 1 (reference) | 1 (reference) | |||
| HIV | 1.04 (20/1920) | 1.90 (1.07, 3.37) | .027 | 1.90 (1.04, 3.48) | .037 | 1.17 (0.58, 2.39) | .658 |
| Mpox vaccination hesitation | |||||||
| Non-HIV | 5.91 (312/5276) | 1 (reference) | 1 (reference) | 1 (reference) | |||
| HIV | 4.11 (79/1920) | 0.68 (0.53, 0.88) | .003 | 0.64 (0.49, 0.84) | .001 | 0.70 (0.53, 0.92) | .011 |
| Consultation hesitation for mpox | |||||||
| Non-HIV | 16.22 (856/5276) | 1 (reference) | 1 (reference) | 1 (reference) | |||
| HIV | 10.78 (207/1920) | 0.62 (0.53, 0.73) | <.001 | 0.64 (0.54, 0.76) | <.001 | 0.74 (0.60, 0.90) | .003 |
Model 1 was a univariate model; model 2 adjusted age group, occupation, ethnicity, educational level, residence and marital status; based on model 2, model 3 additionally adjusted sexual orientation, mpox-related knowledge, sexual diseases excluding HIV, hepatitis C, sexual risky behavior, and other two outcomes. OR = odds ratio; 95%CI = 95% confidence interval.